Phase II study of bevacizumab plus irinotecan on the treatment of relapsed resistant small cell lung cancer
出版年份 2016 全文链接
标题
Phase II study of bevacizumab plus irinotecan on the treatment of relapsed resistant small cell lung cancer
作者
关键词
Small cell lung cancer, Resistant, Irinotecan, Bevacizumab, VEGF, Topoisomerase
出版物
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 77, Issue 4, Pages 713-722
出版商
Springer Nature
发表日期
2016-02-19
DOI
10.1007/s00280-016-2983-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Glioblastoma multiforme: Pathogenesis and treatment
- (2015) Constantinos Alifieris et al. PHARMACOLOGY & THERAPEUTICS
- Validation of standard definition of sensitive versus refractory relapsed small cell lung cancer: A pooled analysis of topotecan second-line trials
- (2014) Andrea Ardizzoni et al. EUROPEAN JOURNAL OF CANCER
- Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
- (2014) E. Basch et al. JNCI-Journal of the National Cancer Institute
- Efficacy and Safety of Oral Topotecan and Bevacizumab Combination as Second-Line Treatment for Relapsed Small-Cell Lung Cancer: An Open-Label Multicenter Single-Arm Phase II Study
- (2013) David R. Spigel et al. Clinical Lung Cancer
- Combination of three cytotoxic agents in small-cell lung cancer
- (2012) G. P. Stathopoulos et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Systematic Analysis of Efficacy of Second-Line Chemotherapy in Sensitive and Refractory Small-Cell Lung Cancer
- (2012) Taofeek K. Owonikoko et al. Journal of Thoracic Oncology
- Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: A phase II multicenter study of the Hellenic Oncology Research Group
- (2012) Giannis Mountzios et al. LUNG CANCER
- Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study
- (2011) Neal E. Ready et al. JOURNAL OF CLINICAL ONCOLOGY
- A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease
- (2010) P. Zatloukal et al. ANNALS OF ONCOLOGY
- Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer
- (2010) Suresh S. Ramalingam et al. CANCER
- Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer
- (2010) Nikolaos Xenidis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer
- (2010) David R. Spigel et al. Journal of Thoracic Oncology
- Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Lung Cancer: A Systematic Review with Meta-Analysis
- (2010) Ping Zhan et al. Journal of Thoracic Oncology
- A Meta-Analysis of Randomized Controlled Trials Comparing Irinotecan/Platinum with Etoposide/Platinum in Patients with Previously Untreated Extensive-Stage Small Cell Lung Cancer
- (2010) Jingwei Jiang et al. Journal of Thoracic Oncology
- Paclitaxel Plus Bevacizumab in Patients with Chemosensitive Relapsed Small Cell Lung Cancer: A Safety, Feasibility, and Efficacy Study from the Hoosier Oncology Group
- (2010) Shadia Jalal et al. Journal of Thoracic Oncology
- Myelotoxicity of oral topotecan in relation to treatment duration and dosage: a phase I study
- (2009) George P. Stathopoulos et al. ANTI-CANCER DRUGS
- Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124
- (2009) Primo N. Lara et al. JOURNAL OF CLINICAL ONCOLOGY
- Tracheoesophageal Fistula Formation in Patients With Lung Cancer Treated With Chemoradiation and Bevacizumab
- (2009) David R. Spigel et al. JOURNAL OF CLINICAL ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer
- (2008) Athanasios G. Pallis et al. LUNG CANCER
- Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients
- (2008) Zeki Ustuner et al. MEDICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search